CSS
RDY icon

Cubist Systematic Strategies’s Dr. Reddy's Laboratories RDY Stock Holding History

Cubist Systematic Strategies’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,410
Closed -$270K – 3834
2024
Q1 		$270K Sell
18,410
-20,920
-53% -$305K ﹤0.01% 2923
2023
Q4 		$547K Sell
39,330
-645,920
-94% -$8.64M ﹤0.01% 2475
2023
Q3 		$9.16M Buy
685,250
+422,145
+160% +$5.71M 0.07% 418
2023
Q2 		$3.32M Sell
263,105
-52,065
-17% -$608K 0.02% 1099
2023
Q1 		$3.59M Buy
315,170
+149,170
+90% +$1.61M 0.02% 1197
2022
Q4 		$1.72M Buy
166,000
+112,470
+210% +$1.21M 0.01% 1977
2022
Q3 		$560K Sell
53,530
-91,110
-63% -$970K ﹤0.01% 3071
2022
Q2 		$1.6M Buy
144,640
+115,500
+396% +$1.26M 0.01% 2056
2022
Q1 		$325K Buy
29,140
+10,915
+60% +$124K ﹤0.01% 2794
2021
Q4 		$238K Buy
+18,225
New +$230K ﹤0.01% 2943
2021
Q2 		– Sell
-42,010
Closed -$516K – 3065
2021
Q1 		$516K Buy
+42,010
New +$540K 0.01% 1937
2020
Q4 		– Sell
-24,840
Closed -$346K – 2685
2020
Q3 		$346K Sell
24,840
-18,170
-42% -$217K 0.01% 1935
2020
Q2 		$456K Buy
+43,010
New +$438K 0.01% 1635
2020
Q1 		– Sell
-83,035
Closed -$674K – 2393
2019
Q4 		$674K Buy
83,035
+74,995
+933% +$592K 0.01% 1379
2019
Q3 		$61K Sell
8,040
-52,475
-87% -$390K ﹤0.01% 2010
2019
Q2 		$453K Buy
+60,515
New +$476K 0.01% 1542
2019
Q1 		– Sell
-1,280
Closed -$10K – 2393
2018
Q4 		$10K Buy
+1,280
New +$9K ﹤0.01% 1986
2018
Q3 		– Sell
-67,160
Closed -$433K – 2045
2018
Q2 		$433K Buy
67,160
+23,490
+54% +$148K 0.02% 871
2018
Q1 		$286K Sell
43,670
-1,275
-3% -$8.94K 0.02% 1181
2017
Q4 		$338K Buy
+44,945
New +$324K 0.02% 1169
2016
Q2 		– Sell
-27,930
Closed -$252K – 1849
2016
Q1 		$252K Buy
+27,930
New +$250K 0.01% 1087

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cubist Systematic Strategies's RDY Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 18,410 shares — an estimated $270K sold.

Cubist Systematic Strategies first reported a position in RDY in Q1 2016 and held it in 21 quarters. The position peaked at $9.16M in Q3 2023. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 18,410 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $270K.
  • Cubist Systematic Strategies first reported a position in Dr. Reddy's Laboratories in Q1 2016 and held it in 21 quarters.
  • Cubist Systematic Strategies's Dr. Reddy's Laboratories position peaked at $9.16M in Q3 2023.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.